Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation

Differential effects of donor-specific HLA antibodies in living versus deceased donor transplant

(2018) E. G. Kamburova et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Impact of pretransplant donor-specific antibodies on kidney allograft recipients with negative flow cytometry cross-matches

(2018) Hyunwook Kwon et al.   CLINICAL TRANSPLANTATION

Effects of mTOR-Is on malignancy and survival following renal transplantation: A systematic review and meta-analysis of randomized trials with a minimum follow-up of 24 months

(2018) Sebastian Wolf et al.   PLoS One

Anti-CD20 Blocker Rituximab in Kidney Transplantation

(2018) Puneet Sood et al.   TRANSPLANTATION

Unacceptable human leucocyte antigens for organ offers in the era of organ shortage: influence on waiting time before kidney transplantation

(2017) Malte Ziemann et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation

(2017) Stanley C. Jordan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical outcomes of ABO- and HLA-incompatible kidney transplantation: a nationwide cohort study

(2017) Eun Jeong Ko et al.   TRANSPLANT INTERNATIONAL

Kidney Transplant With Low Levels of DSA or Low Positive B-Flow Crossmatch

(2017) Carrie A. Schinstock et al.   TRANSPLANTATION

Value of Donor–Specific Anti–HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss

(2016) Denis Viglietti et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Rituximab as Induction Therapy After Renal Transplantation: A Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety

(2015) M. W. F. van den Hoogen et al.   AMERICAN JOURNAL OF TRANSPLANTATION

One hundred ABO-incompatible kidney transplantations between 2004 and 2014: a single-centre experience

(2015) Stefan Zschiedrich et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Determination of unacceptable HLA antigen mismatches in kidney transplant recipients: recommendations of the German Society for Immunogenetics

(2015) C. Süsal et al.   TISSUE ANTIGENS

Three-Year Outcomes Following 1420 ABO-Incompatible Living-Donor Kidney Transplants Performed After ABO Antibody Reduction

(2015) Gerhard Opelz et al.   TRANSPLANTATION

Quantifying the Risk of Incompatible Kidney Transplantation: A Multicenter Study

(2014) B. J. Orandi et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival

(2013) Alexandre Loupy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab Prevents an Anamnestic Response in Patients With Cryptic Sensitization to HLA

(2013) Andrea A. Zachary et al.   TRANSPLANTATION

Donor-Specific Antibodies Adversely Affect Kidney Allograft Outcomes

(2012) S. Mohan et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation

(2012) Brian D. Tait et al.   TRANSPLANTATION

Efficacy of Induction Therapy with ATG and Intravenous Immunoglobulins in Patients with Low-Level Donor-Specific HLA-Antibodies

(2010) K. Bächler et al.   AMERICAN JOURNAL OF TRANSPLANTATION

A Comprehensive Risk Quantification Score for Deceased Donor Kidneys: The Kidney Donor Risk Index

(2009) Panduranga S. Rao et al.   TRANSPLANTATION